UNSPSC 51111644: Lonidamine

This classification denotes a radiosensitizing agent and multidrug resistance modulator with the molecular formula C15H10Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U78804BIDR, chemically known as 1h-indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)- (9ci) but generally known as lonidamine, which bears US NIH Compound Identifier 39562. European Medicines Agency schedules Lonidamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08571MIG.

UNSPSC 51111644 Lonidamine is a Commodity code covering a specific pharmaceutical product, but the recent state and local activity tagged to it reflects broader pharmacy benefit program restructuring rather than direct procurement of the drug itself. The Texas Health and Human Services Commission posted a Request for Information (RFI) No. HHS0017013 in March 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program — an exploratory solicitation focused on establishing direct contracting relationships between state pharmacy benefit programs and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The RFI sought vendor experience with direct contracting for self-insured employers and state health plans, flexibility with negotiated net pricing models, and capacity for value-based or outcomes-based agreements. This represents a departure from traditional pharmaceutical procurement; the state is conducting foundational market research on vendor capacity rather than issuing a formal competitive solicitation with binding timelines or budget commitments.

The code shows limited recent activity specific to lonidamine procurement. The single RFI from the Texas HHS Commission, due April 3, 2026, was an information-gathering mechanism with no award value, set-aside designations, or formal evaluation criteria specified. The state indicated it would use vendor responses to develop detailed procurement specifications and pricing models for subsequent formal solicitations, meaning no immediate purchasing commitment is evident under this code at present. Geographic activity is concentrated in Texas, and the issuing body is a state health and human services agency rather than a county, municipality, school district, or transit authority.